BE502262A - - Google Patents

Info

Publication number
BE502262A
BE502262A BE502262DA BE502262A BE 502262 A BE502262 A BE 502262A BE 502262D A BE502262D A BE 502262DA BE 502262 A BE502262 A BE 502262A
Authority
BE
Belgium
Prior art keywords
antibiotic
terramycin
streptomycin
mixture
composition
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE502262A publication Critical patent/BE502262A/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE502262D BE502262A (enExample)

Publications (1)

Publication Number Publication Date
BE502262A true BE502262A (enExample)

Family

ID=143821

Family Applications (1)

Application Number Title Priority Date Filing Date
BE502262D BE502262A (enExample)

Country Status (1)

Country Link
BE (1) BE502262A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805975A (en) * 1952-12-31 1957-09-10 Pfizer & Co C Antibiotic embalming process

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805975A (en) * 1952-12-31 1957-09-10 Pfizer & Co C Antibiotic embalming process

Similar Documents

Publication Publication Date Title
JP2676080B2 (ja) 非抗バクテリア性テトラサイクリン組成物
DE69930944T2 (de) Bacillus coagulans-zusammensetzung und deren verwendung
US4229430A (en) Oral composition for improving oral health
Greenstein Povidone‐iodine's effects and role in the management of periodontal diseases: a review
JPH09501702A (ja) 増強された抗生物質組成物
CN1117585C (zh) 具有抗螺杆菌活性的乳链菌素合用甘油单月桂酸酯
CN104114166A (zh) 包含dgla、15-ohepa和/或15-hetre的抗微生物组合物及其使用方法
EP0871438B1 (en) Use of alpha-hydroxy acids in the manufacture of a medicament for the treatment of inflammation
US20220117924A1 (en) Compositions of Glycerol and /or Non-Toxic Amino Acids for Inhibiting and Destroying Biofilm, including Related Methods
EP2165704B1 (fr) Utilisation de l'alvérine dans le traitement des affections cutanées
US6248718B1 (en) Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
JP6249438B2 (ja) 口腔衛生改善活性組成物
JP6600124B2 (ja) 菓子
BE502262A (enExample)
CA2384192C (en) Pharmaceutical composition, comprising eucalyptus oil and orange oil
MC1977A1 (fr) Procede de preparation d'une composition inhibitrice ou destructrice d'au moins un etre vivant unicellulaire,renfermant du fluor f et du lithium li+
WO2022254446A1 (en) Method for the treatment of microbial overgrowth, imbalance and infections
US5112617A (en) Method for controlling cold symptoms
BE469075A (enExample)
BE505709A (enExample)
JP2004534792A (ja) ニトロフラントイン及びウワウルシを含む組成物
Condon et al. Aztreonam concentration in abdominal tissues and bile
CN109985063A (zh) 一种高效抑菌药物组合物及其制备方法与应用
CA1221635A (fr) Composition a activite pharmaceutique amelioree et utilisation de celle-ci pour des usages veterinaires
KR100474534B1 (ko) 치아 질환의 예방 및 치료용 조성물